<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362775">
  <stage>Registered</stage>
  <submitdate>18/07/2012</submitdate>
  <approvaldate>6/08/2012</approvaldate>
  <actrnumber>ACTRN12612000822886</actrnumber>
  <trial_identification>
    <studytitle>Effect of a high potassium diet on endothelial function</studytitle>
    <scientifictitle>Effect of a high potassium diet on endothelial function of healthy persons</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Cardiovascular disease</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Diseases of the vasculature and circulation including the lymphatic system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>This is a randomised crossover study of a 1week diet high in potassium (5690mg or 150mmol/day) versus a 1 week usual potassium (3110mg or 80mmol/day) diet with no washout between diets. Dietary targets are acheived by substituting serves of pasta/rice with serves of potatoes and apples with bananas each day. </interventions>
    <comparator>1 week of usual potassium (3110mg or 80mmol/day) diet</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
    <interventioncode>Lifestyle</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Brachial artery flow meadiated dilatation (FMD) - percentage of dilatation</outcome>
      <timepoint>Measured on completion of each dietary intervention only </timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>nil</outcome>
      <timepoint>nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>BMI greater than 18kg/m2 and less than 30kg/m2 SBP &lt;130mmHg DBP&lt;90mmHg weight stable for 6months </inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Use of antihypertensive medication, systemic steroids, folate supplementation or non-steroidal antiinflammatory
drugs.
Metabolic disease such as liver or kidney disease.
Treated hypertension.
Previous clinical cardiovascular disease.
Unable to comprehend protocol.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>The study will be advertised publicly. Participants will be enrolled and randomised to treatment order after screening using an online generated balanced random number allocation sequence (randomization.com) by a person independent to the study.</concealment>
    <sequence>The participants are assigned treatment order using a numbered random-allocation sequence generated by using an online generated balanced random number allocation sequence (randomization.com) by a person independent to the study. </sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>30/08/2012</anticipatedstartdate>
    <actualstartdate>12/03/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate>27/05/2013</actualenddate>
    <samplesize>40</samplesize>
    <actualsamplesize>40</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of South Australia</primarysponsorname>
    <primarysponsoraddress>City East Campus
University of South Australia
GPO Box 2471
Adelaide
SA 5000</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of South Australia</fundingname>
      <fundingaddress>City East Campus
University of South Australia
GPO Box 2471
Adelaide
SA 5000</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to determine the effect of a high potassium diet on blood vessel function. A high potassium intake is associated with reduced risk of heart disease however effect of potassium on blood vessel function is not known. We propose increased dietary potassium will improve blood vessel function.</summary>
    <trialwebsite />
    <publication>Blanch, N., et al. (2014). "Effect of high potassium diet on endothelial function." Nutrition, Metabolism and Cardiovascular Diseases 24(9): 983-989.
</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of South Australia Human Research Ethics Committee</ethicname>
      <ethicaddress>PO Box 2471
Adelaide 
SA 5001</ethicaddress>
      <ethicapprovaldate>18/07/2012</ethicapprovaldate>
      <hrec>0000029701</hrec>
      <ethicsubmitdate>29/05/2012</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Associate Professor Jennifer Keogh</name>
      <address>University of South Australia
City East Campus 
North Terrace 
Adelaide SA 5000</address>
      <phone>+61 8 8302 2579</phone>
      <fax />
      <email>jennifer.keogh@unisa.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Associate Professor Jennifer Keogh</name>
      <address>University of South Australia
City East Campus 
North Terrace 
Adelaide SA 5000</address>
      <phone>+61 8 8302 2579</phone>
      <fax />
      <email>jennifer.keogh@unisa.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Associate Professor Jennifer Keogh </name>
      <address>University of South Australia City East Campus North Terrace Adelaide SA 5000</address>
      <phone>+61 8 8302 2579 </phone>
      <fax />
      <email>jennifer.keogh@unisa.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>